within Pharmacolibrary.Drugs.ATC.S;

model S01FA06
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 9.999999999999999e-06,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01FA06</td></tr><td>route:</td><td>ocular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tropicamide is an antimuscarinic (anticholinergic) agent primarily used in ophthalmology to induce mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle) for diagnostic procedures. It is administered topically in the eye and is widely approved and used currently for these purposes.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters based on limited available human data; no detailed published pharmacokinetic compartmental models found in literature.</p><h4>References</h4><ol><li><p>Zhao, X, et al., &amp; Liu, J (2020). An UPLC-MS/MS Method for Simultaneous Determination of Tropicamide and Phenylephrine in Rabbit Ocular Tissues and Plasma. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 36(5) 282–289. DOI:<a href=&quot;https://doi.org/10.1089/jop.2019.0152&quot;>10.1089/jop.2019.0152</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32320311/&quot;>https://pubmed.ncbi.nlm.nih.gov/32320311</a></p></li><li><p>Verma, P, &amp; Ahuja, M (2016). Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide. <i>Drug delivery</i> 23(8) 3043–3054. DOI:<a href=&quot;https://doi.org/10.3109/10717544.2016.1143057&quot;>10.3109/10717544.2016.1143057</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26878398/&quot;>https://pubmed.ncbi.nlm.nih.gov/26878398</a></p></li><li><p>Lovasik, JV (1986). Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide. <i>American journal of optometry and physiological optics</i> 63(10) 787–803. DOI:<a href=&quot;https://doi.org/10.1097/00006324-198610000-00001&quot;>10.1097/00006324-198610000-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3777109/&quot;>https://pubmed.ncbi.nlm.nih.gov/3777109</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01FA06;
